Article

What about a Cheaper "Tin" ACA Plan?

Author(s):

The ACA requires participating insurers to offer plans ranked by the quality and cost of their offerings. The cheapest is labeled bronze, then silver, gold, and platinum. Some policymakers have proposed creating a still cheaper plan that would protect someone from health care bankruptcy, but have high out-of-pocket costs for care.

(Click the play button on the audio player above to listen to this segment of the ACA panel discussion)

This HCPLive audio panel discussion features:

  • Joel Zinberg MD, JD, Associate Clinical Professor of Surgery at Mount Sinai Hospital in New York City
  • David Sandman PhD, Senior Vice President of the New York State Health Foundation
  • Patrick Cronin, New Jersey organizing director for “Get Covered America” a nonprofit with a federal contract to help people sign up for coverage
  • Tom Wilson (moderator), a partner at Kaufman Zita Group and former chairman of the NJ Republican State Committee

The panelists look at how well the ACA is working and discuss whether it is politically vulnerable.

The ACA requires participating insurers to offer plans ranked by the quality and cost of their offerings. The cheapest is labeled bronze, then silver, gold, and platinum. Some have proposed creating a still cheaper plan that would protect someone from health care bankruptcy, but have high out-of-pocket costs for care. Would that increase ACA enrollment?

Sandman says most people opt for a silver plan, and that such plans give good value. Cronin says price is important, but so is quality. Zinberg says that in NY, the bar has always been set high for what health insurance plans must cover but that under the ACA a bare-bones plan might be useful.

“You get what you pay for a copper or tin plan might be better than nothing, but you would very much be under-insured and still very vulnerable” Sandman says.

But Zinberg said the idea could work.

“A catastrophic plan really offers a very good way to insure people at a lower cost. . . particularly for younger people,” Zinberg says.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Yehuda Handelsman, MD: Insulin Resistance in Cardiometabolic Disease and DCRM 2.0 | Image Credit: TMIOA
Hope on the Horizon: 2 Food Allergy Breakthroughs in 2024
Nathan D. Wong, MD, PhD: Growing Role of Lp(a) in Cardiovascular Risk Assessment | Image Credit: UC Irvine
Discussing FDA Approval of Tapinarof Cream for Atopic Dermatitis, with John Browning, MD
Laurence Sperling, MD: Expanding Cardiologists' Role in Obesity Management  | Image Credit: Emory University
Laurence Sperling, MD: Multidisciplinary Strategies to Combat Obesity Epidemic | Image Credit: Emory University
Schafer Boeder, MD: Role of SGLT2 Inhibitors and GLP-1s in Type 1 Diabetes | Image Credit: UC San Diego
© 2024 MJH Life Sciences

All rights reserved.